17/08/2025
The Endocannabinoid System and Colitis: Exploring the clinical data surrounding the use of cannabis for inflammatory bowel disease
Preclinical data supports the use of cannabinoids for gastrointestinal inflammation, but does this translate into patient outcomes?
Part 1 of this series on cannabis for colitis outlined the preclinical data which evaluated the use of cannabis for inflammation of the GI tract. Although the preclinical data largely supports the use of cannabis in combating inflammation, part 2 of this blog will continue to explore cannabis in the context of colitis and inflammatory bowel disease (IBD). This second part of our series transitions from the preclinical insights discussed earlier to an examination of existing clinical data.
Read more here: https://www.cannaspecialists.org/the_endocannabinoid_system_and_colitis_exploring_the_clinical_data
